Lineage Cell Therapeutics In shares owned by Defender Capital
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Defender Capital
from 13F filings
Historical chart of Defender Capital investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Defender Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Defender Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $11M | 6.8M | 1.67 |
| 2025-06-30 | $6.2M | 6.8M | 0.91 |
| 2025-03-31 | $3.2M | 6.3M | 0.50 |
| 2024-12-31 | $3.0M | 6.0M | 0.50 |
| 2024-09-30 | $4.5M | 5.0M | 0.91 |
| 2024-06-30 | $5.0M | 5.0M | 1.00 |
| 2024-03-31 | $7.4M | 5.0M | 1.48 |
| 2023-12-31 | $5.4M | 5.0M | 1.09 |
| 2023-09-30 | $6.1M | 5.2M | 1.18 |
| 2023-06-30 | $7.2M | 5.1M | 1.41 |
| 2023-03-31 | $7.7M | 5.1M | 1.50 |
| 2022-12-31 | $6.0M | 5.1M | 1.17 |
| 2022-09-30 | $5.9M | 5.2M | 1.13 |
| 2022-06-30 | $8.1M | 5.1M | 1.58 |
| 2022-03-31 | $8.0M | 5.0M | 1.59 |
| 2021-12-31 | $12M | 5.0M | 2.45 |
| 2021-09-30 | $13M | 4.8M | 2.65 |
| 2021-06-30 | $14M | 5.0M | 2.85 |
| 2021-03-31 | $12M | 5.0M | 2.35 |
| 2020-12-31 | $8.3M | 4.7M | 1.76 |
| 2020-09-30 | $4.7M | 5.0M | 0.94 |
| 2020-06-30 | $4.0M | 4.6M | 0.87 |
| 2020-03-31 | $3.7M | 4.4M | 0.83 |
| 2019-12-31 | $3.5M | 4.0M | 0.89 |
| 2019-09-30 | $3.7M | 3.8M | 0.98 |